Literature DB >> 35152319

Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections.

Parvin Askari1, Masoud Yousefi2, Mohsen Foadoddini3, Alireza Neshani4,5,6, Mahdi Aganj4,6,7, Nasim Lotfi8, Aref Movaqar4,6, Kiarash Ghazvini9,10, Mohammad Hasan Namaei11.   

Abstract

Antibiotic resistance is already widespread in the world, and it has become a great health problem. Therefore, comprehensive efforts are needed to minimize the resistance. The exploration of alternative therapies may offer a more targeted approach with less susceptibility to resistance. Even though antimicrobial peptides (AMPs) have been introduced as emerging antibiotic sources, they are not widely discussed in the literature. Since Neisseria infections show resistance to different types of antibiotics, the purpose of this review was to discuss the currently investigated AMPs with anti-Neisseria properties. In the present review, we provide an overview of 24 AMPs with in vitro anti-Neisseria properties.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35152319     DOI： 10.1007/s00284-022-02767-y

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN： 0343-8651            Impact factor:   2.188


  72 in total

Review 1.  A review of vaccine research and development: meningococcal disease.

Authors:  Marc P Girard; Marie-Pierre Preziosi; Maria-Teresa Aguado; Marie Paule Kieny
Journal:  Vaccine       Date:  2006-03-31       Impact factor: 3.641

2.  Synthesis and antimicrobial activity of dermaseptin S1 analogues.

Authors:  Dianella Savoia; Remo Guerrini; Erika Marzola; Severo Salvadori
Journal:  Bioorg Med Chem       Date:  2008-07-20       Impact factor: 3.641

Review 3.  Antimicrobial peptides: promising compounds against pathogenic microorganisms.

Authors:  J Cruz; C Ortiz; F Guzmán; R Fernández-Lafuente; R Torres
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 4.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

Review 5.  Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Ann N Y Acad Sci       Date:  2011-08       Impact factor: 5.691

6.  Cephalosporin Resistance in Neisseria gonorrhoeae.

Authors:  Manju Bala; Seema Sood
Journal:  J Glob Infect Dis       Date:  2010-09

Review 7.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

Review 8.  Pathogenesis of Neisseria gonorrhoeae and the Host Defense in Ascending Infections of Human Fallopian Tube.

Authors:  Jonathan D Lenz; Joseph P Dillard
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

9.  The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate.

Authors:  Freda E-C Jen; Evgeny A Semchenko; Christopher J Day; Kate L Seib; Michael P Jennings
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

10.  The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.

Authors:  Oriana Simonetti; Oscar Cirioni; Federico Mocchegiani; Ivana Cacciatore; Carmela Silvestri; Leonardo Baldassarre; Fiorenza Orlando; Pamela Castelli; Mauro Provinciali; Marco Vivarelli; Erika Fornasari; Andrea Giacometti; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.